(87 days)
Not Found
No
The summary describes a simple mechanical device (sequential compression sleeves) and makes no mention of AI, ML, or any related concepts.
Yes
The device is described as a prophylaxis for deep vein thrombosis or pulmonary embolism, which are medical conditions, indicating a therapeutic purpose.
No
This device is described as "Sequential compression sleeves" intended "as a prophylaxis for the formation of deep vein thrombosis or pulmonary embolism." Its purpose is preventative, not to diagnose a condition.
No
The device description explicitly states "Reprocessed Used Disposable Sequential Compression Sleeves," which are physical hardware components. The summary does not mention any software functionality.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to increase venous comment contrallym in por as a prophylaxis for the formation of deep vein thrombosis or pulmonary embolism in non ambulatory patients. This describes a physical intervention on the patient's body to prevent a condition, not a test performed on a sample taken from the body to diagnose or monitor a condition.
- Device Description: The device is described as "Reprocessed Used Disposable Sequential Compression Sleeves." This is a physical device applied externally to the patient.
- Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Providing diagnostic or monitoring information based on sample analysis
- Using reagents or assays
Therefore, this device falls under the category of a therapeutic or preventative medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Sequential compression sleeves are intended to increase venous comment contrallym in por as a prophylaxis for the formation of deep vein thrombosis or pulmonary embolism in non ambulatory patients.
Sequential compression sleeves are single patient use devices only
Product codes
JOW
Device Description
Reprocessed Used Disposable Sequential Compression Sleeves
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
non ambulatory patients
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5800 Compressible limb sleeve.
(a)
Identification. A compressible limb sleeve is a device that is used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/2 description: The image shows the address of the Food and Drug Administration. The address is 9200 Corporate Boulevard, Rockville MD 20850. The text is left-aligned and in a simple font.
NOV 2 0 2002
Medical Device Services c/o Mr. Mark W. Aldana President 1001 Slaton Hwy. Lubbock, TX 79404
Re: K022753
Trade Name: Reprocessed Used Disposable Sequential Compression Sleeves Regulation Number: 21 CFR 870.5800 Regulation Name: Pumps and Sleeves Regulatory Class: Class II (two) Product Code: JOW Dated: August 9, 2002 Received: August 13, 2002
Dear Mr. Aldana:
This letter corrects our substantially equivalent letter of November 14, 2002 regarding the incorrect applicant.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Mr. Mark W. Aldana
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
B. Z. Jantzen, M.D.
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Page I of I
510)k) Number:
Device Name:
Indications For Use
Sequential compression sleeves are intended to increase venous comment contrallym in por as a prophylaxis for the formation of deep vein thrombosis or pulmonary embolism in non ambulatory patients.
Sequential compression sleeves are single patient use devices only
Image /page/2/Figure/11 description: The image contains a text instruction. The instruction says, "(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF, NEEDED)". This instruction is likely intended for a form or document where users should not write in a specific area and can continue on another page if necessary. The text is written in a formal tone.
Image /page/2/Figure/12 description: The image shows a document related to the Concurrence of CDRH, Office of Device Evaluation (ODE). It includes references to Division 510(k) and mentions "Division of Cardiovascular & Respiratory Devices". The document also contains the number K022753 and a date, 11/13/02, along with the terms "Prescription Use" and "Over-The-Counter Use", indicating the intended use of the device.